Skip to content

Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome

Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03636789
Acronym
OCRIS
Enrollment
61
Registered
2018-08-17
Start date
2018-10-26
Completion date
2021-11-05
Last updated
2022-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Radiologically Isolated Syndrome (RIS)

Brief summary

This study aims to investigate the prevalence of subclinical oculomotor disorders in a population of patients with radiologically isolated syndrome.

Interventions

OTHERNeurological consultation

study of horizontal, vertical, reflex and voluntary saccades, and of horizontal and vertical ocular pursuit by a BrainTracker eye-oculography system

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* The patient must have given his informed consent and signed the consent form. * The patient must be affiliated or beneficiary of a health insurance plan. * The patient is at least 18 years old (≥) and under 50 years old (≤). * Patients with radiologically isolated syndrome according to the criteria of Okuda et al. (2009) * Diagnosis of a radiologically isolated syndrome confirmed by the national expert center of Nice for less than 3 years.

Exclusion criteria

* The subject participates in another study. * The subject is in an exclusion period determined by a previous study. * The subject is under guardianship, curatorship or safeguard of justice. * The patient is pregnant or breastfeeding * The subject refuses to sign the consent. * It is not possible to give the subject informed information. * Patient presenting a pathological neurological examination. * Patient with visual acuity less than 5/10 or with ocular instability

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the occurrence of oculomotor disordersDay 0using a video-oculographic recording system

Secondary

MeasureTime frameDescription
To establish the prevalence of each of the different types of oculomotor abnormalities that constitute the oculomotor disorderDay 0number
To identify a correlation between oculomotor disorders and MRI abnormalities.Day 0
To identify a correlation between oculomotor disorders and the cognitive impairment test (Symbol Digit Modalities Test)Day 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026